reviewPharmacological ResearchMar 13, 2019Closed access

Properties of FDA-approved small molecule protein kinase inhibitors

RRRobert Roskoski

Blue Ridge Research and Consulting (United States)

PubMed
Indexed incrossrefdoajpubmed

Abstract

No abstract available for this paper.

Citation impact

544
total citations
FWCI
54.39
Percentile
100%
References
232
Citations per year

Authors

1

Topics & keywords

Topics
Keywords
  • Medicine
  • Cancer research
  • Sirolimus
  • Everolimus
  • Tyrosine kinase
  • Pharmacology
  • Tofacitinib
  • Janus kinase
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.